doi: 10.1016/0277-5379(82)90117-1.
Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide
- PMID: 6956514
- DOI: 10.1016/0277-5379(82)90117-1
Item in Clipboard
Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide
Eur J Cancer Clin Oncol.
1982 May.
No abstract available
Similar articles
-
Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1605-9. doi: 10.1016/0360-3016(79)90782-x. Int J Radiat Oncol Biol Phys. 1979. PMID: 583418 No abstract available.
-
m-AMSA as a probe for transport phenomena associated with anthracycline resistance.Biochem Pharmacol. 1984 Apr 1;33(7):991-3. doi: 10.1016/0006-2952(84)90505-7. Biochem Pharmacol. 1984. PMID: 6585205
-
Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in mice.Eur J Cancer Clin Oncol. 1983 Nov;19(11):1607-13. doi: 10.1016/0277-5379(83)90093-7. Eur J Cancer Clin Oncol. 1983. PMID: 6688994
-
Is the P388 murine tumor no longer adequate as a drug discovery model?Invest New Drugs. 1987;5(1):3-20. doi: 10.1007/BF00217664. Invest New Drugs. 1987. PMID: 3298130 Review. No abstract available.
-
Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle.Cancer Treat Rev. 1984 Mar;11 Suppl A:63-72. doi: 10.1016/0305-7372(84)90044-6. Cancer Treat Rev. 1984. PMID: 6375864 Review. No abstract available.
Cited by
-
In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).Br J Cancer. 1989 Dec;60(6):838-44. doi: 10.1038/bjc.1989.376. Br J Cancer. 1989. PMID: 2574988 Free PMC article.
-
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.Cancer Chemother Pharmacol. 1992;31(1):46-52. doi: 10.1007/BF00695993. Cancer Chemother Pharmacol. 1992. PMID: 1360876
-
Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo.Cancer Chemother Pharmacol. 1992;31(3):255-7. doi: 10.1007/BF00685557. Cancer Chemother Pharmacol. 1992. PMID: 1361163
-
Topoisomerase II in multiple drug resistance.Cytotechnology. 1993;12(1-3):137-54. doi: 10.1007/BF00744662. Cytotechnology. 1993. PMID: 7765323 Review.
-
Characterization of an etoposide-resistant human K562 cell line, K/eto.Jpn J Cancer Res. 1991 Sep;82(9):1035-43. doi: 10.1111/j.1349-7006.1991.tb01940.x. Jpn J Cancer Res. 1991. PMID: 1657846 Free PMC article.